Literature DB >> 27591177

Outcome of long interval radiological surveillance of side branch pancreatic duct-involved intraductal papillary mucinous neoplasm in selected patients.

Yazan S Khaled1, Muhammed Mohsin2, Kavi Fatania2, Ada Yee2, Robert Adair2, Maria Sheridan2, Christian Macutkiewicz2, Amer Aldouri2, Andrew M Smith3.   

Abstract

INTRODUCTION: Side branch IPMN (SB-IPMN) of the pancreas has a malignancy rate between 10 and 20%. We hypothesized that surveillance at longer intervals on selected patients with SB-IPMN might be indicated.
METHODS: This is a retrospective study of prospectively collected data of 276 patients presenting from 2000 to 2010. After 2007, we opted to screen our patients with longer intervals, initially at 12 months then 24 months using MR if no "worrisome features" were present.
RESULTS: Complete data sets for 261 patients were analysed and patients were aged 78 (40-91) years. 232 patients had sole SB-IPMN while 92% were incidental (n = 209) and 8% were symptomatic (n = 24). Single SB-IPMN accounted for 84% (n = 195) of all cases; maximum diameter of 15.5 (5-60) mm. The median follow up duration was 46 (32-53) months. Short interval radiological surveillance (3-9 months) was 39% (n = 90), while long interval surveillance (12-36 months) was performed in 61% (n = 142). The rate of pancreatic resection, due to concern for the development of pancreatic cancer, in the short and long interval surveillance groups was 4.4% (n = 4) and 3.5% (n = 5) respectively; p = 0.78.
CONCLUSION: Our data suggests no difference in outcome between long and short interval MR surveillance of SB-IPMN patients.
Copyright © 2016. Published by Elsevier Ltd.

Entities:  

Mesh:

Year:  2016        PMID: 27591177      PMCID: PMC5094481          DOI: 10.1016/j.hpb.2016.06.007

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  22 in total

1.  Branch duct intraductal papillary mucinous neoplasms: does cyst size change the tip of the scale? A critical analysis of the revised international consensus guidelines in a large single-institutional series.

Authors:  Klaus Sahora; Mari Mino-Kenudson; William Brugge; Sarah P Thayer; Cristina R Ferrone; Dushyant Sahani; Martha B Pitman; Andrew L Warshaw; Keith D Lillemoe; Carlos F Fernandez-del Castillo
Journal:  Ann Surg       Date:  2013-09       Impact factor: 12.969

Review 2.  International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas.

Authors:  Masao Tanaka; Suresh Chari; Volkan Adsay; Carlos Fernandez-del Castillo; Massimo Falconi; Michio Shimizu; Koji Yamaguchi; Kenji Yamao; Seiki Matsuno
Journal:  Pancreatology       Date:  2006       Impact factor: 3.996

3.  Liberal resection for (presumed) Sendai negative branch-duct intraductal papillary mucinous neoplasms--also not harmless.

Authors:  Camilo Correa-Gallego; Murray F Brennan; Yuman Fong; T Peter Kingham; Ronald P DeMatteo; Michael I DʼAngelica; William R Jarnagin; Peter J Allen
Journal:  Ann Surg       Date:  2014-03       Impact factor: 12.969

4.  Sendai Consensus Guidelines for Branch-duct IPMN: Guidelines Are Just Guidelines.

Authors:  Brian K P Goh
Journal:  Ann Surg       Date:  2015-08       Impact factor: 12.969

5.  Intraductal papillary mucinous tumors of the pancreas comprise 2 clinical subtypes: differences in clinical characteristics and surgical management.

Authors:  M Kobari; S Egawa; K Shibuya; H Shimamura; M Sunamura; K Takeda; S Matsuno; T Furukawa
Journal:  Arch Surg       Date:  1999-10

6.  Natural history of pancreatic intraductal papillary mucinous tumor of branch duct type: follow-up study by magnetic resonance cholangiopancreatography.

Authors:  Hiroyuki Irie; Kengo Yoshimitsu; Hitoshi Aibe; Tsuyoshi Tajima; Akihiro Nishie; Tomohiro Nakayama; Daisuke Kakihara; Hiroshi Honda
Journal:  J Comput Assist Tomogr       Date:  2004 Jan-Feb       Impact factor: 1.826

7.  Experience with 208 resections for intraductal papillary mucinous neoplasm of the pancreas.

Authors:  Thomas Schnelldorfer; Michael G Sarr; David M Nagorney; Lizhi Zhang; Thomas C Smyrk; Rui Qin; Suresh T Chari; Michael B Farnell
Journal:  Arch Surg       Date:  2008-07

8.  Management of branch duct-type intraductal papillary mucinous tumor of the pancreas based on magnetic resonance imaging.

Authors:  J K Sai; M Suyama; Y Kubokawa; K Yamanaka; H Tadokoro; Y Iida; N Sato; K Suda; B Nobukawa; T Maehara
Journal:  Abdom Imaging       Date:  2003 Sep-Oct

Review 9.  Utility of the sendai consensus guidelines for branch-duct intraductal papillary mucinous neoplasms: a systematic review.

Authors:  Brian K P Goh; Damien M Y Tan; Mac M F Ho; Tony K H Lim; Alexander Y F Chung; London L P J Ooi
Journal:  J Gastrointest Surg       Date:  2014-03-26       Impact factor: 3.452

10.  Small (Sendai negative) branch-duct IPMNs: not harmless.

Authors:  Stefan Fritz; Miriam Klauss; Frank Bergmann; Thilo Hackert; Werner Hartwig; Oliver Strobel; Bogata D Bundy; Markus W Büchler; Jens Werner
Journal:  Ann Surg       Date:  2012-08       Impact factor: 12.969

View more
  1 in total

1.  Identification of a pyruvate-to-lactate signature in pancreatic intraductal papillary mucinous neoplasms.

Authors:  Alan R Penheiter; Dinesh K Deelchand; Emily Kittelson; Sibel Erdogan Damgard; Stephen J Murphy; Daniel R O'Brien; William R Bamlet; Marie R Passow; Thomas C Smyrk; Fergus J Couch; George Vasmatzis; John D Port; Małgorzata Marjańska; Stephanie K Carlson
Journal:  Pancreatology       Date:  2017-11-14       Impact factor: 3.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.